AstraZeneca-BMS Merger Denied; Drones & AI Transform Pharma

A senior source denies that AstraZeneca and Bristol Myers Squibb are in merger talks. This cools speculation about a potential deal. What's interesting is that drone delivery is moving into live pharmacy operations, with Cleveland Clinic and Arrive AI pushing this forward. Separately, Kenco's AI rollout shows how quickly agentic AI is impacting 3PL operations. Finally, TailorMed and WeInfuse are partnering to integrate medication access support into infusion workflows. This aims to help identify financial assistance for infusion patients more quickly. The bottom line is these developments could change how patients access medication and receive treatment.